A carregar...

The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells

The development of drug resistance represents a major complication in the effective treatment of breast cancer. Epigenetic therapy, through the use of histone deacetylase inhibitors (HDACi) or demethylation agents, is an emerging area of therapeutic targeting in a number of ontological entities, par...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: RHODES, LYNDSAY V., NITSCHKE, ASHLEY M., SEGAR, H. CHRIS, MARTIN, ELIZABETH C., DRIVER, JENNIFER L., ELLIOTT, STEVEN, NAM, SEUNG YOON, LI, MENG, NEPHEW, KENNETH P., BUROW, MATTHEW E., COLLINS-BUROW, BRIDGETTE M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3982613/
https://ncbi.nlm.nih.gov/pubmed/21971930
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2011.1488
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!